2022 Conference Partners
Meeting Partners
KARL STORZ has extensive experience that enables it to offer the right solutions for urological procedures, combining proven telescopes and instruments with specially coordinated devices. KARL STORZ is leading the way in things that matter: creativity, flexibility, and expertise. Discover new technologies that change the way you look at your patients - see beyond expectations with KARL STORZ.
Learn more at karlstorz.com
Mobile Medical Technology provides a mobile operating theatre for the treatment of kidney stones and other urological procedures. The mobile lithotripsy unit is equipped with a state-of-the-art lithotripter, the Storz Modulith SLX-F2, which was designed and built in Switzerland.
In June 2021, the new mobile lithotripsy unit was launched after years of planning and hard work. The new unit was custom-built with durability and high performance in mind, both on the road and in the theatre.
Since 1995, the lithotripsy unit travels on a regular four-week circuit and treats patients across New Zealand in both private and public hospitals.
Learn more at mobilemedical.co.nz
Meeting Supporters
Cxbladder is a family of non-invasive genomic urine tests optimised for the detection and management of bladder cancer, combining clinical risk factors with gene expression markers to quickly and accurately detect the presence or absence of bladder cancer.
Cxbladder accurately rules out patients with haematuria or being monitored for bladder cancer recurrence, who have a low probability of bladder cancer and can safely avoid further invasive tests.
As an adjunct to cystoscopy, Cxbladder is proven to adjudicate atypical cytology and equivocal cystoscopy.
With performance validated in 12 peer-reviewed studies, Cxbladder is trusted by New Zealand urologists on more than 10,000 patients.
Learn more at www.cxbladder.com/nz/
Merck Sharp & Dohme (New Zealand) Limited (MSD) is a subsidiary of Merck & Co. Inc., Kenilworth, NJ, USA. MSD was established in New Zealand in 1962.
In New Zealand, MSD provides medicines, vaccines and biologic therapies across a broad range of therapeutic areas. These include; oncology, anaesthesia, HIV/AIDS, antibacterials/antifungals and immunisations.
MSD is one of the few pharmaceutical companies still conducting clinical trials in New Zealand and as at June 2020 invested approximately $NZ78 million in local clinical research. Current research programs include oncology, infectious diseases, endocrinology, chronic cough and vaccines.
Learn more at msd-newzealand.com
Since its inception in 1919, Olympus has continuously evolved to become one of the world’s leading medical technology manufacturers. We are committed to the development of early detection and minimally invasive solutions, aiming to improve the level of patient care. Through innovative technologies and products, we are pioneering and redefining trends and market standards. As an end-to-end urology provider, we are active in the spheres of BPH, NMIBC, stone management, and laparoscopic urology.
Learn more at olympus.co.nz